Efficacy and safety of a two‐drug direct‐acting antiviral agent regimen ruzasvir 180 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4, 5 or 6

Journal of Viral Hepatitis ◽

10.1111/jvh.13132 ◽

2019 ◽

Author(s):

Eric Lawitz ◽

Edward Gane ◽

Jordan J. Feld ◽

Maria Buti ◽

Graham R. Foster ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Antiviral Agent ◽

Efficacy And Safety ◽

Virus Genotype ◽

Direct Acting Antiviral ◽

Chronic Hepatitis C Virus ◽

Download Full-text

Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis

Journal of Gastroenterology ◽

10.1007/s00535-016-1174-4 ◽

2016 ◽

Vol 51 (7) ◽

pp. 741-747 ◽

Author(s):

Hidenori Toyoda ◽

Takashi Kumada ◽

Toshifumi Tada ◽

Koichi Takaguchi ◽

Toru Ishikawa ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Antiviral Therapy ◽

Virus Genotype ◽

Safety And Efficacy ◽

Direct Acting Antiviral ◽

Chronic Hepatitis C Virus ◽

Download Full-text

Erratum to: Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis

Journal of Gastroenterology ◽

10.1007/s00535-016-1192-2 ◽

2016 ◽

Vol 51 (7) ◽

pp. 750-750

Author(s):

Hidenori Toyoda ◽

Takashi Kumada ◽

Toshifumi Tada ◽

Koichi Takaguchi ◽

Toru Ishikawa ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Antiviral Therapy ◽

Virus Genotype ◽

Safety And Efficacy ◽

Direct Acting Antiviral ◽

Chronic Hepatitis C Virus ◽

Download Full-text

Efficacy and safety of direct-acting antiviral agent regimens in a real-world cohort of adult Chinese patients with chronic hepatitis C virus infection

Liver Research ◽

10.1016/j.livres.2020.05.002 ◽

2020 ◽

Vol 4 (2) ◽

pp. 101-107

Author(s):

Jinyuan Wei ◽

Yongyu Mei ◽

Jianping Li ◽

Jing Yuan ◽

Xiaohua Yang ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Antiviral Agent ◽

Chinese Patients ◽

Efficacy And Safety ◽

Hepatitis C Virus Infection ◽

Direct Acting Antiviral ◽

Chronic Hepatitis C Virus ◽

Download Full-text

MAGELLAN-1, Part 2: glecaprevir and pibrentasvir for 12 or 16 weeks in patients with chronic hepatitis C virus genotype 1 or 4 and prior direct-acting antiviral treatment failure

Journal of Hepatology ◽

10.1016/s0168-8278(17)30432-4 ◽

2017 ◽

Vol 66 (1) ◽

pp. S83-S84 ◽

Author(s):

F. Poordad ◽

S. Pol ◽

A. Asatryan ◽

M. Buti ◽

D. Shaw ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Treatment Failure ◽

Antiviral Treatment ◽

Virus Genotype ◽

Direct Acting Antiviral ◽

Chronic Hepatitis C Virus ◽

Download Full-text

Efficacy and Safety of Direct-Acting Antiviral Therapy in Patients With Chronic Hepatitis C Virus Infection: A Real-World Single-Center Experience in Tianjin, China

Frontiers in Pharmacology ◽

10.3389/fphar.2020.00710 ◽

2020 ◽

Vol 11 ◽

Author(s):

Huan Xia ◽

Chengzhen Lu ◽

Yin Wang ◽

Silvere D. Zaongo ◽

Yue Hu ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Efficacy And Safety ◽

Hepatitis C Virus Infection ◽

Single Center ◽

Direct Acting Antiviral ◽

Single Center Experience ◽

Chronic Hepatitis C Virus ◽

Download Full-text

Direct-acting antiviral therapy for chronic hepatitis C virus genotype 4 infection: Exploring new regimens

Health Science Reports ◽

10.1002/hsr2.106 ◽

2019 ◽

Vol 2 (3) ◽

pp. e106 ◽

Author(s):

Hidenori Toyoda

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Antiviral Therapy ◽

Chronic Hepatitis C ◽

Virus Genotype ◽

Direct Acting Antiviral ◽

Chronic Hepatitis C Virus ◽

Download Full-text

EXPEDITION-I: efficacy and safety of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus genotype 1, 2, 4, 5 or 6 infection and compensated cirrhosis

Journal of Hepatology ◽

10.1016/s0168-8278(17)30269-6 ◽

2017 ◽

Vol 66 (1) ◽

pp. S3-S4 ◽

Author(s):

X. Forns ◽

S. Lee ◽

J. Valdes ◽

S. Lens ◽

R. Ghalib ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Efficacy And Safety ◽

Virus Genotype ◽

Compensated Cirrhosis ◽

Chronic Hepatitis C Virus

Download Full-text

Cost–Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong

Digestive Diseases and Sciences ◽

10.1007/s10620-020-06281-8 ◽

2020 ◽

Author(s):

Man-Fung Yuen ◽

Sze-Hang Liu ◽

Wai-Kay Seto ◽

Lung-Yi Mak ◽

Shelby L. Corman ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hong Kong ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Utility ◽

Direct Acting Antiviral ◽

Chronic Hepatitis C Virus ◽

Download Full-text

Efficacy and safety of ruzasvir 60 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4 or 6 infection

Journal of Viral Hepatitis ◽

10.1111/jvh.13079 ◽

2019 ◽

Vol 26 (6) ◽

pp. 675-684 ◽

Author(s):

Eric Lawitz ◽

Fred Poordad ◽

Leah J. Anderson ◽

Michelle Vesay ◽

Michelle M. Kelly ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Efficacy And Safety ◽

Virus Genotype ◽

Chronic Hepatitis C Virus

Download Full-text

Cost-effectiveness of direct-acting antiviral regimen ombitasvir/paritaprevir/ritonavir in treatment-naïve and treatment-experienced patients infected with chronic hepatitis C virus genotype 1b in Japan

Journal of Medical Economics ◽

10.1080/13696998.2016.1206908 ◽

2016 ◽

Vol 19 (12) ◽

pp. 1144-1156 ◽

Author(s):

Suchin Virabhak ◽

Kikuo Yasui ◽

Kiyotaka Yamazaki ◽

Scott Johnson ◽

Dominic Mitchell ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Virus Genotype ◽

Direct Acting Antiviral ◽

Chronic Hepatitis C Virus ◽

Treatment Naïve ◽

Download Full-text